Vitamin d improves corticosteroid efficacy and attenuates its side-effects in an animal model of asthma

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 1, 2014, Pages 53-61

  Mehta, Anita A ^a   Agrawal, Ashok D ^a   Appanna, Vasu ^b   Chaudagar, Kiranj K ^a  

^a L M COLLEGE OF PHARMACY   (India)

^b LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Bolus dose; Dexamethasone; Ovalbumin; Single dose

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN E; INTERLEUKIN 5; NITRIC OXIDE; OVALBUMIN; VITAMIN D; CORTICOSTEROID;

ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BOLUS INJECTION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; EXPERIMENTAL ASTHMA; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MALE; MENTAL DISEASE; MONOTHERAPY; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PRIORITY JOURNAL; RAT; ANIMAL; ASTHMA; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODEL; DRUG COMBINATION; PATHOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; IMMUNOGLOBULIN E; MALE; RATS; RATS, WISTAR; TREATMENT OUTCOME; VITAMIN D;

EID: 84920660508     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0323     Document Type: Article

References (80)

1. Adams, J.S., and Hewison, M. 2008. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metabol. 4(2): 80–90. doi:10.1038/ncpendmet0716. PMID: 18212810.
2. Adcock, I.M., Caramori, G., and Chung, K.F. 2008. New targets for drug development in asthma. Lancet, 372: 1073–1087. doi:10.1016/S0140-6736(08)61449-X. PMID:18805336.
3. Barnes, P.J. 1995. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332(13): 868–875. doi:10.1056/NEJM199503303321307. PMID:7870143.
4. Barnes, P.J., and Adcock, I. 1993. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14: 436–441. doi:10.1016/0165-6147(93)90184-L. PMID:7510080.
5. Barnes, P.J., and Adcock, I.M. 2009. Glucocorticoid resistance in inflammatory diseases. Lancet, 373(9678): 1905–1917. doi:10.1016/S0140-6736(09)60326-3. PMID:19482216.
6. Bergman, P., Lindh, A.U., Björkhem-Bergman, L., and Lindh, J.D. 2013. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One, 8(6): e65835. doi:10.1371/journal.pone.0065835. PMID:23840373.
7. Boon, N., Hul, G.B., Stegen, J.H., Sluijsmans, W.E., Valle, C., Langin, D., et al. 2007. An intervention study of the effects of calcium intake on faecal fat excretion, energy metabolism and adipose tissue mRNA expression of lipidmetabolism related proteins. Int. J. Obes. (Lond.), 31: 1704–1712. doi:10.1038/sj.ijo.0803660. PMID:17579637.
8. Bouillon, R., Garmyn, M., Verstuyf, A., Segaert, S., Casteels, K., and Mathieu, C. 1995. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities analogs. Eur. J. Endocrinol. 133: 7–16. doi:10.1530/eje.0.1330007. PMID:7627339.
9. Brindley, D.N. 1995. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int. J. Obes. Relat. Metab. Disord. 19(Suppl. 1): S69–S75. PMID:7550541.
10. Broekkamp, C.L., Rijk, H.W., Joly-Gelouin, D., and Lloyd, K.L. 1986. Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur. J. Pharmacol. 126(3): 223–229. doi:10.1016/0014-2999(86)90051-8. PMID:2875886.
11. Cantorna, M.T. 2011. Why do T cells express the vitamin D receptor? Ann. N.Y. Acad. Sci. 1217: 77–82. doi:10.1111/j.1749-6632.2010.05823.x. PMID:21114675.
12. Chambers, E.S., and Hawrylowicz, C.M. 2011. The impact of vitamin D on regulatory T cells. Curr. Allergy Asthma Rep. 11: 29–36. doi:10.1007/s11882-010-0161-8. PMID:21104171.
13. Chang, J.M., Kuo, M.C., Kuo, H.T., Hwang, S.J., Tsai, J.C., Chen, H.C., et al. 2004. 1-α,25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J. Lab. Clin. Med. 143: 14–22. doi:10.1016/j.lab.2003.08.002. PMID: 14749681.
14. Cheng, S., Massaro, J.M., Fox, C.S., Larson, M.G., Keyes, M.J., McCabe, E.L., et al. 2009. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes, 59: 242–248. doi:10.2337/db09-1011. PMID:19833894.
15. Chertow, B.S., Sivitz, W.I., Baranetsky, N.G., Clark, S.A., and Waite, A. 1983. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology, 113: 1511–1518. doi:10.1210/endo-113-4-1511. PMID:6352248.
16. Clore, J.N., and Thurby-Hay, L. 2009. Glucocorticoid-induced hyperglycemia. Endocr. Pract. 15: 469–474. doi:10.4158/EP08331.RAR. PMID:19454391.
17. Cohen-Lahav, M., Douvdevani, A., Chaimovitz, C., and Shany, S. 2007. The antiinflammatory activity of 1,25dihydroxy vitamin D3 in macrophages. J. Steroid Biochem. Mol. Biol. 103: 558–562. doi:10.1016/j.jsbmb.2006.12.093. PMID: 17267205.
18. Dong, X., Craig, T., Xing, N., Bachman, L.A., Paya, C.V., Weih, F., et al. 2003. Direct transcriptional regulation of RelB by 1alpha, 25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritric cell function. J. Biol. Chem. 278: 49378–49385. doi:10.1074/jbc.M308448200. PMID: 14507914.
19. Drevets, W.C., and Furey, M.L. 2010. Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol. Psychiatry, 67(5): 432–438. doi:10.1016/j.biopsych.2009.11.021. PMID:20074703.
20. Duan, W., Kua, I.C., Selvarajan, S., Chua, K.Y., Bay, B.H., and Wong, W.S. 2003. Anti-inflammatory effects of genistein, a tyrosine kinase inhibitor, on guinea pig model of asthma. Am. J. Respir. Crit. Care Med. 167: 185–192. doi:10.1164/rccm.200205-420OC. PMID:12406820.
21. Dunlop, B.W., and Nemeroff, C.B. 2007. The role of dopamine in the pathophysiology of depression. Arch. Gen. Psychiatry, 64(3): 327–337. doi:10.1001/archpsyc.64.3.327. PMID:17339521.
22. Dunlop, T.W., Vaisanen, S., Frank, C., Molnar, F., Sinkkonen, L., Carlberg, C., et al. 2005. The human peroxisome proliferator-activated receptor δ gene is a primary target of 1_, 25-dihydroxyvitamin D3 and its nuclear receptor. J. Mol. Biol. 349(2): 248–260. doi:10.1016/j.jmb.2005.03.060. PMID:15890193.
23. Ettinger, W.H., Jr., and Hazzard, W.R. 1988. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism, 37: 1055–1058. doi:10.1016/0026-0495(88)90067-4. PMID:3185288.
24. Forman, J.P., Giovannucci, E., Holmes, M.D., Bischoff-Ferrari, H.A., Tworoger, S.S., Willett, W.C., et al. 2007. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 49: 1063–1069. doi:10.1161/HYPERTENSIONAHA.107.087288. PMID:17372031.
25. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499–502. PMID:4337382.
26. Gannage-Yared, M.H., Chedid, R., Khalife, S., Azzi, E., Zoghbi, F., and Halaby, G. 2009. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur. J. Endocrinol. 160: 965–971. doi:10.1530/EJE-08-0952. PMID:19289535.
27. Gloth, F.M., III, Alam, W., and Hollis, B. 1999. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J. Nutr. Health Aging, 3(1): 5–7. PMID:10888476.
28. Gorman, S., Kuritzky, L.A., Judge, M.A., Dixon, K.M., McGlade, J.P., Mason, R.S., et al. 2007. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 179: 6273–6283. doi:10.4049/jimmunol.179.9.6273. PMID:17947703.
29. Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S., and Tannenbaum, S.R. 1982. Analysis of nitrate and [15N] nitrate in biological fluids. Anal. Biochem. 126: 131–138. doi:10.1016/0003-2697(82)90118-X. PMID: 7181105.
30. Griffin, M.D., Xing, N., and Kumar, R. 2003. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 23: 117–145. doi:10.1146/annurev.nutr.23.011702.073114. PMID:12651965.
31. Harms, L.R., Burne, T.H., Eyles, D.W., and McGrath, J.J. 2010. Vitamin D and the brain. Best Pract. Res. Clin. Endocrinol. Metab. 25(4): 657–669. doi:10.1016/j.beem.2011.05.009. PMID:21872806.
32. Hewison, M. 2010. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 39(2): 365–379. doi:10.1016/j.ecl.2010.02.010. PMID:20511058.
33. Humble, M. 2000. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy. Acta Psychiatr. Scand. Suppl. 402: 28–36. doi:10.1034/j.1600-0447.2000.02605.x. PMID:10901156.
34. Hypponen, E., and Power, C. 2006. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care, 29: 2244–2246. doi:10.2337/dc06-0946. PMID:17003300.
35. Hypponen, E., Boucher, B.J., Berry, D.J., and Power, C. 2008. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes, 57: 298–305. doi:10.2337/db07-1122. PMID:18003755.
36. Ish-Shalom, S., Segal, E., Salganik, T., Raz, B., Bromberg, I.L., and Vieth, R. 2008. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J. Clin. Endocrinol. Metab. 93: 3430–3435. doi:10.1210/jc.2008-0241. PMID:18544622.
37. Jones, A.P., Tulic, M.K., Rueter, K., and Prescott, S.L. 2012. Vitamin D and allergic disease: sunlight at the end of the tunnel. Nutrients, 4(1): 13–28. doi:10.3390/nu4010013. PMID:22347615.
38. Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J., and Waterloo, K. 2008. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J. Intern. Med. 264(6): 599–609. doi:10.1111/j.1365-2796.2008.02008.x. PMID:18793245.
39. Kalueff, A.V., Lou, Y.R., Laaksi, I., and Tuohimaa, P. 2004. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport, 15(8): 1271–1274. doi:10.1097/01.wnr.0000129370.04248.92. PMID:15167547.
40. Karhapää, P., Pihlajamäki, J., Pörsti, I., Kastarinen, M., Mustonen, J., Niemelä, O., et al. 2010. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J. Intern. Med. 268(6): 604–610. doi:10.1111/j.1365-2796.2010.02279.x. PMID:20831628.
41. Kennett, G.A., Dickinson, S.L., and Curzon, G. 1985. Enhancement of some 5-HT depressant behavioral responses following repeated immobilization in rats. Brain Res. 330: 253–263. doi:10.1016/0006-8993(85)90684-5. PMID:4039215.
42. Konradsen, S., Ag, H., Lindberg, F., Hexeberg, S., and Jorde, R. 2008. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur. J. Nutr. 47: 87–91. doi:10.1007/s00394-008-0700-4. PMID:18320256.
43. Lange, N.E., Litonjua, A., Hawrylowicz, C.M., and Weiss, S. 2009. Vitamin D the immune system and asthma. Expert Rev. Clin. Immunol. 5: 693–702. doi:10.1586/eci.09.53. PMID:20161622.
44. Lansdowne, A.T., and Provost, S.C. 1998. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl.), 135(4): 319–323. doi:10.1007/s002130050517. PMID:9539254.
45. Lemire, J.M., Archer, D.C., Beck, L., and Spiegelberg, H.L. 1995. Immunosuppressive actions of 1,25-dihydroxy vitamin D3: preferential inhibition of Th1 functions. J. Nutr. 125(6 Suppl.): 1704S–1708S. PMID:7782931.
46. Lloyd, A.J., Ferrier, I.N., Barber, R., Gholkar, A., Young, A.H., and O'Brien, J.T. 2004. Hippocampal volume change in depression: Late-and early-onset illness compared. Br. J. Psychiatry, 184: 488–495. doi:10.1192/bjp.184.6.488. PMID:15172942.
47. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. 2013. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. PMID: 23245604.
48. Maestro, B., Molero, S., Bajo, S., Dávila, N., and Calle, C. 2002. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem. Funct. 20(3): 227–232. doi:10.1002/cbf.951. PMID:12125099.
49. Majewska, M.D. 1987. Steroids and brain activity. Biochem. Pharmacol. 36: 3781–3788. doi:10.1016/0006-2952(87)90437-0. PMID:2825703.
50. Masoli, M., Fabian, D., Holt, S., and Beasley, R. 2004. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy, 59: 469–478. doi:10.1111/j.1398-9995.2004.00526.x. PMID:15080825.
51. Matheu, V., Bäck, O., Mondoc, E., and Issazadeh-Navikas, S. 2003. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: Enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 112: 585–592. doi:10.1016/S0091-6749(03)01855-4. PMID:13679819.
52. McEwen, B.S., Davis, P.G., Parsons, B., and Pfaff, D.W. 1979. The brain as a target for steroid hormone action. Annu. Rev. Neurosci. 2: 65–112. doi:10.1146/annurev.ne.02.030179.000433. PMID:395885.
53. Mileusnic, R., Kanazir, S., Ruzdijic, S., and Rakic, L. 1986. Effects of cortisol treatment on protein synthesis in septum and hippocampus of rat brain. Neuroendocrinology, 42: 306–310. doi:10.1159/000124456. PMID:3960273.
54. Mirescu, C., and Gould, E. 2006. Stress and adult neurogenesis. Hippocampus, 16: 233–238. doi:10.1002/hipo.20155. PMID:16411244.
55. Moghadam-Kia, S., and Werth, V.P. 2010. Prevention and treatment of systemic glucocorticoid side effects. Int. J. Dermatol. 49(3): 239–248. doi:10.1111/j.1365-4632.2009.04322.x. PMID:20465658.
56. Provvedini, D.M., Tsoukas, C.D., Deftos, L.J., and Manolagas, S.C. 1986. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J. Immunol. 136: 2734. PMID:3007606.
57. Puchacz, E., Stumpf, W.E., Stachowiak, E.K., and Stachowiak, M.K. 1996. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain. Res. Mol. Brain. Res. 36(1): 193–196. doi:10.1016/0169-328X(95)00314-I. PMID:9011759.
58. Rainey, W.E., Rodgers, R.J., and Mason, J.I. 1992. The role of bovine lipoproteins in the regulation of steroidogenesis and HMG-CoA reductase in bovine adrenocortical cells. Steroids, 57: 167–173. doi:10.1016/0039-128X(92)90003-R. PMID:1325689.
59. Reis, J.P., Von Muhlen, D., and Miller, E.R. 2008. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol. 159: 41–48. doi:10.1530/EJE-08-0072. PMID:18426812.
60. Rothschild, A.J., Langlais, R.J., Schatzberg, A.F., Miller, M.M., Saloman, M.S., Lerbinger, J.E., et al. 1985. The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci. 36(26): 2491–2501. doi:10.1016/0024-3205(85)90145-6. PMID:2409422.
61. Sapolsky, R.M. 1996. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress, 1: 1–19. doi:10.3109/10253899609001092. PMID:9807058.
62. Sapolsky, R.M., and Pulsinelli, W.A. 1985. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science, 229: 1397–1400. doi:10.1126/science.4035356. PMID:4035356.
63. Scheff S.W., and Cotman, C.W. 1982. Chronic glucocorticoid therapy alters axon sprouting in the hippocampal gyrus. Exp. Neurol. 76: 644–654. doi:10.1016/0014-4886(82)90131-5. PMID:7084379.
64. Searing, D.A., Zhang, Y., Murphy, J.R., Hauk, P.J., Goleva, E., and Leung, D.Y. 2010. Decreased serum svitamin D levels in children with asthma are associated with increased corticosteroid use. J. Allergy Clin. Immunol. 125(5): 995–1000. doi:10.1016/j.jaci.2010.03.008. PMID:20381849.
65. Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2: 389–400. PMID:12093005.
66. Shipowick, C.D., Moore, C.B., Corbett, C., and Bindler, R. 2009. Vitamin D and depressive symptoms in women during the winter: a pilot study. Appl. Nurs. Res. 22(3): 221–225. doi:10.1016/j.apnr.2007.08.001. PMID:19616172.
67. Stene, M., Panagiotis, N., Tuck, M.L., Sowers, J.R., Mayes, D., and Berg, G. 1980. Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration, and circadian changes in normal man. J. Clin. Endocrinol. Metab. 51: 1340–1345. doi:10.1210/jcem-51-6-1340. PMID:6255004.
68. Steru, L., Chermat, R., Thierry, B., and Simon, P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology, 85: 367–370. doi:10.1007/BF00428203. PMID:3923523.
69. Tanaka, Y., Seino, Y., and Ishida, M. 1984. Effects of vitamin D3 on the pancreatic secretion of insulin andsomatostatin. Acta Endocrinol. 105: 528–533. PMID: 6144227.
70. Tang, J., Zhou, R., Luger, D., Zhu, W., Silver, P.B., and Grajewski, R.S. 2009. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 182: 4624–4632. doi:10.4049/jimmunol.0801543. PMID:19342637.
71. Topilski, I., Flaishon, L., Naveh, Y., Harmelin, A., Levo, Y., and Shachar, I. 2004. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur. J. Immunol. 34: 1068–1076. doi:10.1002/eji.200324532. PMID:15048717.
72. Urry, Z., Xystrakis, E., Richards, D.F., McDonald, J., Sattar, Z., Cousins, D.J., et al. 2009. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha, 25-dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest. 119: 387–398. doi:10.1172/JCI32354. PMID:19139565.
73. Van Loon, G.R., Sole, M.L., Kamble, A., Kim, C., and Green, S. 1977. Differential responsiveness of central noradrenergic and dopaminergic neuron tyrosine hydroxylase to hypophysectomy, ACTH and glucocorticoid administration. Ann. N.Y. Acad. Sci. 297: 284–294. doi:10.1111/j.1749-6632.1977.tb41861.x. PMID:29550.
74. Van Raalte, D.H., Ouwens, D.M., and Diamant, M. 2009. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur. J. Clin. Invest. 39(2): 81–93. doi:10.1111/j.1365-2362.2008.02067.x. PMID:19200161.
75. Vieth, R., Kimball, S., Hu, A., and Walfish, P.G. 2004. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr. J. 3: 8. doi:10.1186/1475-2891-3-8. PMID:15260882.
76. Wittke, A., Weaver, V., Mahon, B.D., August, A., and Cantorna, M.T. 2004. Vitamin D receptor deficient mice fail to develop experimental allergic asthma. J. Immunol. 173: 3432–3436. doi:10.4049/jimmunol.173.5.3432. PMID:15322208.
77. Wolkowitz, O.M., Sutton, M., Koulu, M., Labarca, R., Wilkinson, L., Doran, A., et al. 1986. Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity. Eur. J. Pharmacol. 122: 329–338. doi:10.1016/0014-2999(86)90413-9. PMID:3709658.
78. Yu, S., Holsboer, F., and Almeida, O.F. 2008. Neuronal actions of glucocorticoids: Focus on depression. J. Steroid Biochem. Mol. Biol. 108: 300–309. doi:10.1016/j.jsbmb.2007.09.014. PMID:17933520.
79. Zhou, Y., Zhou, X., and Wang, X. 2008. 1,25-Dihydroxyvitamin D3 prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase. Allergy Asthma Proc. 29: 258–267. doi:10.2500/aap.2008.29.3115. PMID:18534083.
80. Zimmerman, J., Fainaru, M., and Eisenberg, S. 1984. The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism, 33: 521–526. doi:10.1016/0026-0495(84)90006-4. PMID:6727652.